Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2023 Feb 15.
Published in final edited form as: Nat Metab. 2022 Aug 15;4(8):978–994. doi: 10.1038/s42255-022-00619-4

A practical guide for the analysis, standardization, and interpretation of oxygen consumption measurements

Ajit S Divakaruni 1,*, Martin Jastroch 2
PMCID: PMC9618452  NIHMSID: NIHMS1825548  PMID: 35971004

Abstract

Measurement of oxygen consumption is a powerful and uniquely informative experimental technique. It can help identify mitochondrial mechanisms of action upon pharmacologic and genetic interventions, and characterize energy metabolism in physiology and disease. The conceptual and practical benefits of respirometry have made it a frontline technique to understand how mitochondrial function can interface with – and in some cases control – cell physiology. Nonetheless, an appreciation of the complexity and challenges involved with such measurements is required to avoid common experimental and analytical pitfalls. Here we provide a practical guide to oxygen consumption measurements covering the selection of experimental models and instrumentation, as well as recommendations for the collection, interpretation, and normalization of data. These guidelines are provided with the intention of aiding experimental design and enhancing the overall reputability, transparency, and reliability of oxygen consumption measurements.

INTRODUCTION

Measurements of oxygen consumption rates have been central to the recent, resurgent interest in mitochondrial metabolism1. In particular, the validation and adoption of microplate-based respirometry has revolutionized the field of bioenergetics by making measurements accessible to non-specialists and enabling studies showing how mitochondrial function is altered in response to growth factor signaling2, cytokine stimulus3,4, and cell activation5,6. An appreciation that mitochondrial metabolism is central to an array of physiological processes beyond classic ‘metabolic’ tissues7,8 – coupled with turnkey solutions to study respiration in a range of model systems never previously feasible9 – has resulted in a rapid, broad adoption of the measurements.

The oxygen consumption rate is an integrative and comprehensive readout of cellular metabolism and mitochondrial function. Because respiration is coupled to ATP synthesis10,11, many processes that either make or consume ATP can be studied with respirometry so long as the experimental conditions allow that process to control the overall oxygen consumption rate. For pathways that generate ATP through oxidative phosphorylation, respiration can be used to assess altered activity of specific enzymes or metabolic nodes by offering isolated mitochondria or permeabilized cells energy substrates that each require different metabolic pathways for oxidation but all terminate in oxygen consumption12.

In addition to these conceptual strengths, there are several practical benefits to respirometry. Both major types of commonly used analytical instrumentation – chamber-based platinum electrodes13 and microplate-based fluorescent readings9,14 – offer a fairly low barrier of entry for the non-specialist. Both platforms also offer real-time, visual readouts that allow rapid experimental iteration unlike destructive, end-point assays that measure gene and protein expression or metabolite levels. The ability to monitor real-time oxygen consumption rates also enables studies measuring acute mitochondrial responses to pharmacologic inhibitors or effectors that can alter the cellular activation state.

As the widespread adoption of this technique has occurred in a relatively short period, the trial-and-error and iteration necessary to develop the best practices remains ongoing. Thus, despite the utility and approachability of these measurements, challenges and complexity remain regarding the design and interpretation of respirometry studies. Several manuscripts have been published detailing the utility of respirometry ranging from conceptual12,1520 to instructional9,13,2123.

As a companion to these, this perspective may help serve as a starting point to foster the reputability, transparency, and trustworthiness of in vitro and ex vivo oxygen consumption data. We discuss considerations for choosing whether isolated mitochondria, cells, or three-dimensional multicellular models is most appropriate for a given question, supplementing existing guidelines17,24. For each of these systems we review the relative strengths and weaknesses of common measurement platforms (summarized in Table 1) and provide recommendations for data collection, normalization, and presentation. Building upon published works that define respiratory parameters and provide rational flowcharts for hypothesis testing12,16,25, we aim to help the novice and experienced user alike in identifying common pitfalls, avoiding data misinterpretation, and establishing shared practices for respirometry data.

Table 1:

Comparison of commonly used measurement platforms

Chamber-based platinum electrode Plate-based fluorescence/phosphorescence
Common vendors • Oroboros Instruments
• Hansatech Instruments Ltd.
• Rank Brothers Ltd.
• Strathkelvin Instruments Ltd.
• Agilent Seahorse XF Analyzer
• Cayman Oxygen Consumption Rate Assay
• Agilent MitoXpress
Cost Range from $1–2K to fully integrated instruments at $40–50K Assay kits for use with multimode plate reader at ~$400. Seahorse XF Analyzers range from $40K (8-well) to >$200K (96-well).
Time and throughput Single (or dual) chamber setups measure one (or two) technical replicates at a time. Each experiment takes ~15 minutes, and the chamber must be cleaned between runs. 96-well microplate-based approaches allow several experimental groups, each with multiple replicates, to be assessed simultaneously. Each experiment takes up to 75–90 minutes (for XF Analyzer) and plates are disposable.
Sample size required Larger chamber volumes require increased amounts of material. Yield from clinical samples or some primary cell preparations may be prohibitively small. The XF Analyzer reduces the sample material required by orders of magnitude by dramatically reducing the size of the measurement chamber.
Additional measurements beyond O 2 Can be multiplexed with electrodes or fiberoptic detectors sensitive to other analytes to measure ROS, pH, Ca2+, mitochondrial membrane potential, etc. Simultaneously measures changes in extracellular pH, and recent corrections allow quantitation of lactate efflux.
Data analysis Easy access to raw experimental data for manual calculation of rates. Propriety XF analysis software automatically calculates rates. Rates with fluorescent or phosphorescent assay kits are easily calculated manually.
Sensitivity and quantitation Provides quantitative oxygen consumption rates reliable for very low respiratory rates and at low oxygen tensions Fluorescent assay kits only provide relative, qualitative comparisons. User-friendly XF Analyzer software is quantitative and matches results from platinum-based electrodes across a range of oxygen consumption rates.
Real-time response to injections Manual injection of effector compounds allows unlimited additions, which can be helpful for precise titrations. The XF Analyzer allows up to 4 injections at user-defined time points. For assay kits, the properties of the multimode plate reader used will dictate the injection scheme.
Benefits when working with isolated mitochondria Multiplexed measurements offer multiparametric analysis of isolated mitochondria; Reliable readings of very low oxygen consumption rates; Easy access to raw data avoids calculation artifacts. Allows simultaneous measurements with several distinct oxidizable substrates across multiple experimental groups (e.g., WT vs. KO) to identify pathway-specific mechanisms of action. Amenable to small sample sizes such as mitochondria isolated from clinical biopsies or specific tissue regions.
Benefits when working with intact cells Normalization is straightforward, as defined amounts of cells in suspension are assayed. All of the sample material contributes equally to the reading. Preservation of ECM interactions and cellular structures enhances physiological relevance. Can study small sample sizes such primary cell populations or clinical samples. Concurrent measurements of glycolysis (XF Analyzer) allow calculation of real-time ATP production rates.
Benefits when with 3D structures Chamber size easily accommodates tissue pieces. Can be used to assess respiration in single organoids such as individual pancreatic islets or cancer cell spheroids.

CHOICE OF MODEL SYSTEM AND EXPERIMENTAL DESIGN

ISOLATED MITOCHONDRIA

General considerations

The decision to measure respiration in isolated mitochondria rather than intact cells or multicellular models may be driven by both practical and scientific considerations. Practically, isolating mitochondria is often preferred when studying non-hematopoetic tissues from adult animals. Ample mitochondria can be isolated with relative ease from many adult rodent tissues such as heart, brain, and skeletal muscle21,2628. Even in tissues where primary cells can be readily isolated, such as liver29 or adipose tissue30, considerations of yield, viability, and sample quality often make isolated mitochondria an attractive choice.

Only in rare cases should mitochondria be isolated from primary or cultured cells, as the yield, purity, and quality are often sub-optimal. A far more useful option is to selectively permeabilize the cellular plasma membrane31,32. This approach requires less starting material and avoids artifacts generated by the isolation procedure.

Measuring respiration in isolated mitochondria is appropriate when a metabolic phenotype is expected to be driven by changes intrinsic to mitochondria, or when examining drug candidates for a mitochondrial mechanism of action or potential toxicity. The mechanism underlying changes in the respiratory rate can range from altered activity of a single rate-controlling enzyme (e.g. electron transport chain complexes33,34, mitochondrial dehydrogenases35,36, inner membrane transporters37,38, etc.) to changes that globally affect abundance and activity of mitochondrial proteins (e.g. ‘proofreading’ of mitochondrial DNA39, cristae density40, translation of mitochondrial-encoded proteins41, maintenance of inner membrane phospholipid composition42,43, vitamin and cofactor biosynthesis4446, etc.). Oxygen consumption in isolated mitochondria is expected to change when the protein or pathway of interest is a rate-controlling step for substrate oxidation under appropriate assay conditions. For example, reduced activity of pyruvate dehydrogenase (PDH) or respiratory complex I should slow the rate of oxygen consumption when isolated mitochondria are offered pyruvate as an oxidizable substrate, but not succinate, as its oxidation requires neither PDH nor complex I12 (Figure 1).

Figure 1 -. Microplate-based respirometry enables simultaneous measurement of oxygen consumption supported by different substrates.

Figure 1 -

(a) Schematic showing how isolated mitochondria or permeabilized cells can be offered multiple oxidizable substrate pairs for pathway-specific analysis. Substrates requiring complex I for oxidation are shown in blue, those bypassing complex I to feed electrons directly to the ubiquinone pool are in red, and those delivering electrons directly to complex IV are in green. Pyr/Mal, pyruvate with malate; Glu/Mal, glutamate with malate; Palm carn/Mal, palmitoyl carnitine with malate; Succ/Rot, succinate with rotenone; G-3-P/Rot, glycerol-3-phosphate with rotenone; Asc/TMPD/AA, ascorbate with TMPD and antimycin A. Proton leak and other processes that consume the membrane potential independently of ATP synthesis are shown with a dashed line. (b) The approach can identify specific metabolic alterations intrinsic to mitochondria. In this hypothetical example, isolated mitochondria from genetically modified knockout (KO) animals show respiratory deficits with complex I-linked substrates but not with others, suggesting gene ablation causes a primary defect in respiratory complex I activity or mitochondrial NAD+ homeostasis relative to wild-type (WT) mice. Excess ADP is offered (State 3 respiration) so the respiratory rate is largely set by the rate of substrate oxidation and respiratory chain activity, and minimally restrained by consumption of the membrane potential. Abbreviations are as before. PC, palmitoyl carnitine (c) Microplate-based respirometry also shows the need to pick an appropriate, physiologically relevant set of substrates based on the tissue being studied. As represented here, mouse heart mitochondria can support relatively high rates of long chain fatty acid oxidation compared to glutamate oxidation, but this relationship is flipped in mitochondria isolated from mouse brain.

In some circumstances, indirect alterations to mitochondria may also be detected by respirometry with isolated mitochondria. Changes in cytoplasmic enzyme activity or cell signaling may manifest in altered oxygen consumption rates in isolated mitochondria, but only if there are downstream, direct effects that persist after isolation. Examples include cytoplasmic calcium dysregulation that causes mitochondrial calcium overload28,47 and disrupted iron homeostasis as is observed in models of Friedreich’s Ataxia48. Several circumstances that would change the oxygen consumption rate in whole cells or tissues – notably alterations in substrate import49 or the glycolytic provision of pyruvate to mitochondria5 – would not be expected to affect respiration in isolated mitochondria. Even changes in cell signaling that directly target mitochondrial proteins (e.g. phosphorylation status of mitochondrial dehydrogenases) quite often do not persist upon organelle isolation and measurement. It is therefore important to consider whether the hypothesized alteration to mitochondria is expected to be present in isolated mitochondria before planning experiments.

Designing experiments

As a testament to their pioneering work, the parameters defining mitochondrial respiration set forth by Chance and Williams over 60 years ago have remained mostly unchanged50. These historical definitions of respiratory ‘states’ (e.g. State 3, State 4, etc.) persist today, though slightly altered for practical reasons, and are defined in Table 211,51,52. Regardless of the measurement platform, isolated mitochondria are almost always offered sufficient ADP and excess oxidizable substrates (e.g. pyruvate with malate, succinate with rotenone, etc.) to stimulate robust rates of oxygen consumption. The selection of what substrates to offer mitochondria should be driven by the experimental question and the physiology of the tissue from which the mitochondria are isolated. Almost all studies are strengthened by comparing multiple, distinct oxidative pathways (Figure 1).

Table 2: Defining respiratory ‘states’ in isolated mitochondria and permeabilized cells.

Mitochondrial respiration can be classified by – or partitioned into – different steady-’states’. Their definitions stem from Chance and Williams50 with some refinement11, and are commonly used for measurements with isolated mitochondria and permeabilized cells. For plate-based respirometry, rates should always be corrected for the background signal by addition of electron transport chain inhibitors.

Term Definition for respiratory state in mitochondria or permeabilized cells
State 2 Respiratory rate in the presence of exogenously added substrates – such as pyruvate and malate or succinate with rotenone. With no added ADP present to drive ATP synthesis, the rate is slow and set by other processes that consume the membrane potential (e.g. proton leak or calcium cycling).
State 3 Respiration in the presence of oxidizable substrates and ADP. The ADP is usually offered in excess, though in chamber-based setups it can be delivered via ADP-regenerating systems (e.g. hexokinase + glucose). This high rate reflects the capacity of mitochondria to generate ATP.
State 4 or 4 O After ADP is fully converted to ATP (State 4), or the ATP synthase is inhibited with oligomycin (State 4o), the respiratory rate slows. This rate is similar to State 2 but typically lower, as oligomycin removes any respiration linked to residual ATP turnover in State 2.
State 3 U Uncouplers such as FCCP, dinitrophenol (DNP), or Bam15 estimate the maximal capacity of mitochondria to oxidize energy substrates. In principle, this rate should equal or surpass the State 3 rate, because any rate limitations associated with ATP synthesis are removed (e.g. ADP/ATP exchange across the inner membrane). The appropriate concentration of uncoupler must be properly determined by titration.
Additional parameters
P/O ratio The P/O ratio is the amount of ATP phosphorylated (P) for every molecule of oxygen consumed (O). Current estimates of maximal P/O ratios are 2.727 for oxidation of NADH and 1.636 for FADH294,120122.
Respiratory Control Ratio (RCR) This metric, defined as the ratio of State 3:State 4(O), is used as an estimate for how tightly mitochondrial substrate oxidation is coupled to synthesis of ATP. It has traditionally been used as a measure of quality control for mitochondrial isolations.

This control over substrate provision in a reductionist system has its advantages and disadvantages17. Stripping away contributions from cell signaling, hormonal control, diffusion gradients, and cytoplasmic metabolism provides a simple, well-defined experimental system. Additionally, the researcher has near-total control over the assay conditions and pathways contributing to the respiratory rate. The measurements are also inherently controlled for changes in mitochondrial content between tissues from different experimental groups.

What is gained in mechanistic insight from a straightforward system, however, sacrifices physiological relevance. The respiratory ‘states’ defined in Table 2 represent extreme conditions that rarely, if ever, exist during healthy physiology. For example, isolated mitochondria given excess ADP and a particular substrate (State 3) does not reproduce physiological circumstances in which the energy demand fluctuates (e.g. cardiac muscle contraction and relaxation, periodic neuronal synaptic activity, etc.) and the availability of energy substrates is a changing, complex mixture rather than one or two carbon sources53. Moreover, the experiments can be inherently biased from the a priori selection of the substrate(s) to be studied. For example, reduced oxidation of branched chain amino acids is thought to be associated with insulin resistance and cardiovascular disease54,55, but these pathways are rarely examined when following traditional respirometry protocols. Changes in mitochondrial morphology and ultrastructure can also be lost upon mitochondrial isolation56, and the isolation procedure itself may introduce artifacts of subselection30, particularly when tissues from different experimental groups are altered by pathology.

INTACT CELLS

General considerations

The considerations for choosing to study respiration in cells are straightforward. Practically, it is almost always advised to study respiration in cells when the model systems used for other aspects of the research project are cultured or primary cells. Isolating mitochondria from cells often results in poor quality mitochondria unsuitable for functional analysis, and also disrupts cellular architecture (e.g. neuronal projections or other extensions from cell bodies) that can leave behind important populations of mitochondria.

Measuring respiration in intact cells also preserves interactions mitochondria share with organelles and cellular structures such as the endoplasmic reticulum57 or lipid droplets30. As a result, changes in respiration that could be affected by multiple biological processes – including cell signaling7, ion homeostasis58, interorganelle communication30,57, substrate import49 and mobilization of internal energy stores, etc. – are retained by studying intact cells but likely would be lost upon mitochondrial isolation.

Similarly, a distinct advantage of cell-based respirometry is that it can capture changes driven by alterations in mitochondrial biogenesis or dynamics. Information about mitochondrial content per cell and many ultrastructural changes (i.e. whether mitochondria exist predominantly in fragmented units or a filamentous network) can be reflected in the cellular oxygen consumption rate but are often lost upon mitochondrial isolation. As such, intact cells are generally a more appropriate model to investigate the effects of transcriptional networks that control mitochondrial content59 or proteins that govern mitochondrial motility and the balance between fusion and fission60.

Of course, a drawback with this increased physiological relevance from studying intact cells is that it necessarily restricts the ability to directly offer mitochondria ADP and various substrates, inhibitors, and cofactors for pathway-specific analysis. Cell-permeable substrate analogs may be added to overcome this issue, but these often show slower kinetics of oxidation than the unmodified substrate and likely do not reflect full metabolic rates61. However, follow-up analysis by permeabilizing the plasma membrane of cells creates large pores that dilute cytoplasmic contents to the experimental medium, thereby allowing direct substrate provision to in situ mitochondria31. These experiments have been historically conducted with plant-based sterol glycosides such as digitonin or saponin32,62, and more recently with plasma membrane-specific recombinant perfringolysin O (rPFO) that does not disrupt mitochondrial membranes22. Regardless of the permeabilization reagent used, these assays enable the rigorous, mechanistic analysis commonly associated with isolated mitochondria to be conducted on cellular samples in response to pharmacologic or genetic manipulation.

As with isolated mitochondria, respirometry in permeabilized cells assesses maximal pathway activity and precludes the ability to assess substrate preference under native, basal conditions. To obtain this information, a powerful experimental technique is to conduct parallel experiments with intact cell respirometry alongside metabolomics and stable isotope tracing18. This approach yields information about pathway-specific fluxes under basal conditions and provides a level of depth unmatched by oxygen consumption measurements63,64. Quantitative fluxes of individual reactions can be modeled from metabolomics and stable isotope tracing data using metabolic flux analysis (MFA)65, though this is highly specialized and can be computationally intensive.

Designing experiments

Cellular respiration is coupled to ATP synthesis: as the ATP utilization rate of a cell increases or decreases, the rate of oxidative phosphorylation changes correspondingly to match the change in ATP demand. Thus, the basal oxygen consumption rate in cells can reflect alterations in either pathways that generate ATP (i.e. complete oxidation of sugars, amino acids, or fatty acids) or those that consume ATP (e.g. ion homeostasis, biosynthesis, autophagy, motility, etc.)12. In addition to altered rates of ATP utilization, cellular respiration also responds to changes in proton leak pathways66,67 and mitochondrial Ca2+ cycling68,69.

In most cases, measuring respiration in response to a sequence of chemical effectors can discriminate between these possibilities. This classic experiment to measure oxygen consumption in response to the ATP synthase inhibitor oligomycin and the uncoupler FCCP has been conducted for decades, and long before the advent of microplate-based respirometry70,71. Use of these effectors for intact cell respirometry experiments is tremendously informative on multiple levels. Notably, despite using similar compounds, the respiratory parameters are termed differently in intact cells (Table 3) than in isolated mitochondria or permeabilized cells (Table 2), as they substantially differ in meaning.

Table 3: Defining respiratory parameters for intact cells and three-dimensional structures.

Plate-based oxygen consumption measurements have helped standardize respiratory parameters for intact cells, though the broad experimental framework had been established decades prior. It is almost always most informative to report raw, quantitative rates. Nonetheless, internally normalized parameters can be useful when it is difficult to control for cell number or biomass, such as when working with tissue pieces. This scaling is independent of cell number or sample size, and allows comparisons across different laboratories, experimental platforms, and model systems. Further definitions and interpretations of these parameters, as well as guidelines for calculation, have been previously published9,12,16. Specific points are discussed further in the main text.

Term Description of respiratory parameters in intact cells or 3D structures
Basal (or resting/initial) respiration The initial respiratory rate in intact cells or multicellular structures largely reflects the resting ATP demand. In proliferating cells, a substantial portion of this reflects the energetic costs of biosynthesis and cell division. In differentiated cells, the initial rate may be quite low without activation from external, physiologically relevant stimuli. In most cells, roughly 80% of the basal respiratory rate is coupled to ATP synthesis, with the remainder attributable to processes that use the mitochondrial membrane but do not generate ATP66.
Proton leak Oxygen consumption is not completely coupled to ATP synthesis, as a residual respiratory rate persists in the presence of oligomycin. This rate reflects a composite of processes that consume the membrane potential despite ATP synthase inhibition. Changes in proton leak-linked respiration may indicate altered energy expenditure, and can be substantial upon activation of brown adipocytes.
Uncoupler-stimulated (or maximal) respiration As basal respiratory rates are restrained by the ATP demand of the cell, they often do not accurately reflect the ability of a cell to respond to increased energy requirements. Addition of a titrated amount of protonophore, however, decouples (or ‘uncouples’) respiratory chain activity from cellular ATP requirements. The rate estimates the maximal capacity of mitochondria to transport and oxidize energy substrates.
Non-mitochondrial oxygen consumption In microplate-based platforms, mitochondrial respiration should always be corrected by subtracting the rate insensitive to respiratory chain inhibition, usually with the complex I inhibitor rotenone and the complex III inhibitor antimycin A. Apart from experimental conditions where activation of non-mitochondrial oxidases is expected, a substantial component of this rate in the XF Analyzer may be instrument background.
Internally scaled parameters independent of cell number or sample size
Spare/reserve respiratory capacity The spare respiratory capacity is often calculated as the absolute difference between the basal and uncoupler-stimulated rates of respiration. It can also be presented as a ratio-based parameter (i.e. maximal rate:basal rate) as an internally normalized parameter for the relative ability of cells or 3D structures to respond to an increased energy demand.
Coupling efficiency & other measures The fraction of the basal respiratory rate that is coupled to ATP synthesis (i.e. oligomycin-sensitive respiration:basal respiration) can be represented as a percentage to allow for comparison across model systems. In most cell types this is value is around 80%. An additional, internally normalized metric is the ratio of uncoupler-stimulated respiration to the proton leak-linked respiration, sometimes called the ‘cell respiratory control ratio17.’

The basal, unstimulated rate of respiration does not reflect the capacity of a cell to respond to an energy demand during activation. Because in vitro assay conditions do not entirely reproduce the in vivo environment, measuring uncoupler-stimulated respiration provides a way to measure the cellular response to an energetic challenge that may not be apparent under resting, basal conditions58 (discussed further in Box 1). Physiologically relevant stimuli, such as membrane depolarizating agents for electrically excitable cells5, antigen-coated beads for T cells6, or adrenergic stimulation of brown adipocytes or mature cardiomyocytes72, can also be used to better understand the energetic response to cell activation. This ability to easily measure the acute response to physiological effectors is a strength of respirometry compared to stable isotope tracing18,63.

Box 1: Estimating ‘maximal’ cellular respiratory rates with uncouplers.

Oxygen consumption in response to uncouplers – protonophores such as FCCP, DNP, and Bam15 – estimates the maximal activity of the respiratory chain. These compounds decouple (or ‘uncouple’) mitochondrial substrate oxidation from ATP synthesis, relieving any rate limitation imposed by the basal cellular ATP demand.

For standard experiments in intact cells, measuring uncoupler-stimulated respiration can serve two broad purposes. (1) Differences observed in basal respiratory rates could be attributable to changes in either ATP utilization or oxidation of energy substrates. Measuring oxygen consumption independently of ATP synthesis can help distinguish between these two possibilities. (2) Additionally, uncoupled respiration can estimate maximal respiratory rates that may occur in vivo upon cellular activation (e.g. TCR ligation, NMDA receptor activation in neurons, adrenergic stimulation of brown adipocytes or mature cardiomyocytes) that are not reflected in resting, in vitro assays in the absence of physiologically relevant stimulation and microenvironments.

It is critical to properly titrate the concentration of chemical uncoupler to ensure the measurement is a good approximation of the maximal respiratory rate. Importantly, the optimal amount may change upon genetic or pharmacologic modification. Titrations in chamber-based platforms allow several sequential additions to determine the highest achievable rate, and multiple concentrations can be tested in plate-based platforms using sequential additions from the injector ports (or apportioning different measurement groups). Excess uncoupler often results in a steep reduction in the respiratory rate, an observation further discussed elsewhere12. As such, while the term ‘maximal respiration’ is a good operational description of the parameter, it is perhaps more likely that this approach measures the highest achievable rate while minimizing the deleterious effects of chemical uncoupling.

In addition to the choice of exogenous effectors, selection of the medium composition is a critical component for intact cell assays. Cells are generally assayed in medium matching their culture medium such as DMEM or RPMI, and supplemented with multiple oxidizable substrates like glucose, glutamine, and pyruvate to obtain maximal rates of uncoupler-stimulated respiration. Although it is possible to more strictly define the experimental medium and substrates offered, caution should be exercised when making broad conclusions about the results. For example, respiration rates in highly glycolytic cells offered only glucose in a simple salts medium may differ substantially from cells in more complete medium supplemented with glutamine, an often-essential substrate to support energy metabolism and anaplerosis in cultured cells73. An additional complication for plate-based respirometry is the frequent lack of fatty acids in assay medium, which is an important physiological substrate for cardiac and skeletal muscle but often omitted from studies due to technical or practical reasons.

THREE-DIMENSIONAL, MULTICELLULAR MODELS

With all respirometry studies, there exists a tradeoff balancing simplicity and ease of analysis with the physiological relevance of the model system. This is perhaps most apparent with multicellular models and tissue biopsies, and making these experiments more straightforward remains one of the most significant opportunities to advance the field. Obtaining trustworthy measurements can be technically challenging and results can be difficult to interpret, so these are usually not recommended for introductory experiments.

Three-dimensional (3D) systems such as spheriods74, organoids75, and tissue slices76 provide distinct advantages over working with intact cells and isolated mitochondria such as maintaining intercellular communication and microenvironmental gradients that can control metabolic rates. Additionally, given the increased appreciation for metabolic communication between proximal cells, such as between the tumor and stroma77 or the retina and adjacent epithelial cells78, the ability to easily study oxygen consumption in heterogeneous models would be a powerful addition to the current suite of bioenergetic measurements. In certain cases, respirometry studies of whole organisms such as plankton79, C. elegans80, and even slime mold81 can link differences in oxygen consumption to organismal energy budgets using instrumentation designed for in vitro assays.

Predictably, this enhanced physiological relevance is accompanied by considerable technical and analytical challenges. These obstacles have precluded the widespread adoption of respirometry to study three-dimensional models at a scale comparable to isolated mitochondria or intact cells. In particular, it can be difficult to determine whether observed changes in oxygen consumption between 3D samples are due to alterations in catabolism or the delivery of oxygen and substrates to the core of the structure. Nonetheless, respirometry in multicellular models and tissue biopsies is possible, and indeed informative when phenotypes are inextricably linked to their three-dimensional structure82 or it is necessary to determine if an observed phenotype is an artifact of two-dimensional cell culture83. Respiratory parameters for multicellular structures are shared with those for intact cells (Table 3).

Regardless of the model system used, in vitro or ex vivo respirometry results can be linked with whole body oxygen consumption measurements in rodent models from indirect calorimetry in metabolic cages or chambers84,85 (Box 2).

Box 2: Integrating oxygen consumption measurements from the mouse to the molecule.

The measurements of in vitro and ex vivo respirometry discussed here can be meaningfully integrated with whole body oxygen consumption measurements to localize molecular mechanisms underlying bioenergetic phenotypes in animal models. When a distinct phenotype can be associated with altered oxygen consumption in rodent models using metabolic cages or chambers84,85, an integrative analysis using tissue-specific genetic ablation can trace the bioenergetic phenotype to the tissue, cell, and protein(s) involved. An example highlighting this workflow is the discovery of the scaffold protein p62 as a regulator of brown fat thermogenesis. After observing an obese phenotype upon global p62 KO, decreased energy expenditure was only reproduced upon genetic ablation in brown adipose tissue but not in other tissue-specific knockout animals. Respirometry with primary brown adipocytes and isolated mitochondria further localized the effect to an impaired mitochondrial response to β-adrenergic stimulus123.

Similarly, multiple studies have used in vitro respirometry as one of several upfront techniques to characterize genes of unknown function88,124 or molecular mechanisms of drug action31 followed by whole animal studies. Although respirometry monitors the activity of a single enzyme (cytochrome oxidase, or respiratory complex IV), carefully designing experiments allows dozens of upstream or downstream processes to control the overall oxygen consumption rate. As an example, respirometry helped support biochemical and yeast genetic studies identifying the essential components of the mitochondrial pyruvate carrier, MPC1 and MPC2125,126. Although mouse, whole body knockouts of Mpc1 or Mpc2 are embryonically lethal, mice with liver- or skeletal muscle-specific ablation exhibit lower respiratory exchange ratios (RERs)37,127, indicating a shift in the animal towards increased fatty acid oxidation upon reduced mitochondrial pyruvate oxidation. Indeed, liver-specific specific ablation protects from diet-induced hyperglycemia and skeletal muscle-specific loss promotes leanness.

INSTRUMENTATION AND EXPERIMENTAL PLATFORMS

As outlined in Table 1, the major experimental platforms to measure respiration fall into two broad categories: (i) chamber-based setups with platinum, Clark-type electrodes or (ii) microplate-based setups with fluorescent or phosphorescent detection methods. Both instruments have their relative strengths and limitations depending on the model system used and the experimental question.

EXPERIMENTAL THROUGHPUT

A primary benefit of the Seahorse XF Analyzer is that it reduces the sample material required for a single replicate by orders of magnitude relative to platinum-based Clark-type electrodes. This enables analysis of samples from which the mitochondrial yield would be otherwise prohibitively small for meaningful respirometry experiments, such as clinical biopsies21. It also allows the same mitochondria from low-yield preparations to be used for additional parallel experiments. When studying cells, reducing the requisite sample material allows the study of small primary cell populations such as those obtained from rodent models (e.g. brain cells isolated from specific regions, neonatal ventricular myocytes, antigen-specific T cells) or clinical samples86 [e.g. human peripheral blood mononuclear cells (PBMCs)]. By extension, respirometry can easily be conducted on genetically modified samples of immortalized cells as well, where cellular material may be abundant but the volume of expensive reagents required for genetic transformation can be cost-prohibitive.

Additionally, the multi-well format of microplate-based approaches allow simultaneous measurement of 90+ experimental replicates in a single run, providing a throughput unmatched by chamber-based setups. This approach allows oxygen consumption to be used as a straightforward, end-point readout in concentration-response studies of drug candidates that affect cellular energy metabolism87. In isolated mitochondria or permeabilized cells, respiratory rates measured in microplates can be assessed on several distinct substrates in different experimental samples (e.g. wild-type vs. genetic modification) with sufficient technical replicates in a single plate.

As highlighted in Figure 1 and illustrated by the dozens of distinct changes that can alter oxygen consumption rates (see general considerations when working with isolated mitochondria), determining whether changes are observed only in one pathway or matched in several pathways is essential for pinpointing the exact mechanism driving a mitochondrial phenotype29,37,39. Simultaneous measurement of different substrates has also helped reveal that mitochondria isolated from different tissues have varying oxidative capacities for different substrates. Although this may be intuitive, it highlights the benefit of measuring several substrates in parallel when using oxygen consumption to characterize mitochondrial function or identify mechanisms of action. It is also often assumed that the rate limitation(s) for respiration lie exclusively within the electron transport chain, but these assays often reveal that substrate transport, oxidation, or even co-factor levels88,89 frequently control the rate of respiration. Put another way, plate-based respirometry has helped show that defining mitochondrial energetics when studying a single respiratory substrate can be inherently limited or biased by the upfront selection of a ‘best’ or ‘representative’ substrate.

MULTIPLEXING WITH OTHER MEASUREMENTS

Platinum-based, Clark-type electrodes provide a cost-effective and customizable approach to conduct respirometry. Despite the lower throughput relative to plate-based approaches, this approach offers far more flexibility for an individual experiment, particularly when working with isolated mitochondria. Oxygen consumption measurements can be multiplexed with fiberoptic detectors or electrodes that report the mitochondrial membrane potential, pH, external calcium concentration, or reactive oxygen species production for simultaneous measurement of multiple mitochondrial parameters in a given sample90,91. There is also no limit to the number of injections that can be delivered in most chamber-based setups, enabling careful titrations of novel compounds under investigation or uncouplers that require precise titrations to determine the optimal concentration to induce maximal respiratory rates.

On the other hand, multiplexing plate-based respirometry with additional assays almost always requires parallel experiments to measure other aspects of mitochondrial function. Conveniently, though, the limited sample material required for oxygen consumption measurements frequently leaves ample material available for such assays. A notable exception is the simultaneous calculation of extracellular acidification rates with the Seahorse XF Analyzer, which provides additional context to interpret respiratory data and overall energy metabolism when studying intact cells.

These extracellular acidification measurements have been greatly aided by recent corrections that adjust the rates to accurately reflect lactate efflux by accounting for respiratory acidification92,93. These calibrations can estimate the balance between glycolysis and oxidative phosphorylation, and by extension, can be used to estimate cellular ATP production rates93,94. When studying isolated mitochondria or permeabilized cells, these pH readings can be valuable for troubleshooting (e.g. verifying pH of reagents) or specialized assays such as measuring ATP hydrolysis95.

PRESERVING CELLULAR NETWORKS

Microplate-based platforms have been transformative in enabling researchers to study adherent monolayers of cells without dissociation and stirring of suspension cultures. Cell dissociation is required for chamber-based platforms, and disrupts cellular structures and prevents interactions between cells and extracellular matrix (ECM) proteins. Stirring likely introduces shearing stress from having to spin samples at high speeds (though there may also be shearing stress in the XF Analyzer during the mixing phase). The same dissociated cell suspension is often used for multiple technical replicates with platinum electrode chambers, introducing the possibility of time-dependent effects during prolonged suspension such as alkalinization of bicarbonate-containing medium.

Meaningful respirometry studies in intact neurons were previously impossible without microplate-based platforms96, as dislodging adherent cell monolayers separates the cell body from the neurites rich in synaptic mitochondria. Similarly, studying adherent monolayers preserves ECM interactions and likely maintains signaling pathways that regulate energy metabolism during physiological processes such as tumor extravasation or embryogenesis97,98. Microplates can also readily accommodate hematopoetic cells and those from suspension cultures, as cells can be easily centrifuged onto plates coated with a biological adhesive. Though rare, some cell types such as mature primary white adipocytes will not affix well to microplates even with an adhesive, and are best studied in platinum-based electrode chambers to remain floating and stirred.

ACCOMODATING 3D MULTICELLULAR STRUCTURES

A standout benefit for measuring respiration with Clark-type electrode chambers is that they can accommodate tissue samples. The larger volume of these setups can be a drawback when working with cells or isolated mitochondria – as they require far more sample material that microplate-based approaches – but the increased volume is often advantageous when working with 3D samples. The microchamber formed by the XF Analyzer (2.28 μL in the 96- or 8-well instruments; 7 μL in the 24-well instrument) can present physical limitations that preclude measurement of many types of tissue samples.

Nonetheless, microplate-based analysis has been successfully used to measure respiration in several types of multicellular structures83,99102, and is necessary when the sample material is limiting or requires seeding onto ECM protein matrices. For some models, the sensitivity of the XF Analyzer enables analysis of individual structures such as spheroids83 or pancreatic islets101, and therefore can provide a better understanding of the factors that drive metabolic heterogeneity. An additional benefit of a microplate-based approach may be the lack of stirring. The need to constantly mix the sample in platinum-based electrode chambers, though it may aid exposure to pharmacologic compounds or exogenous mitochondrial effectors, likely introduces shearing stress that could artificially increase the basal respiratory rate of less rigid 3D structures.

However, there are further challenges and unknowns in addition to geometric constraints associated with studying multicellular models in microplate-based setups. For example, it is unclear to what extent movement of the sample during the XF Analyzer’s mixing cycle (thereby changing its position relative to the measurement sensor) can affect the measurements. This can be largely avoided by seeding 3D structures onto Matrigel or other adhesives as has been done with islets or intestinal crypts103.

COLLECTING AND ANALYZING DATA

Data from Clark-type electrodes offer total flexibility for calculating respiratory rates and usually unrestricted access to raw data. Rates can be directly extrapolated from the decreases in oxygen concentration in a large, closed reaction chamber (Figure 2a). Some setups provide software which automatically calculate respiratory rates with smoothing and correction algorithms13.

Figure 2 -. Calculation of respiratory rates in common measurement platforms.

Figure 2 -

Hypothetical experiments with isolated mitochondria are presented. (a) (left) Platinum, Clark-type electrodes with closed, glass reaction chambers display linear decreases in oxygen tension, from which the oxygen consumption rate can be directly calculated (right). (b) (left) In the XF Analyzer, the instrument forms a transient, semi-closed ‘microchamber’ to measure the decrease in oxygen tension over a defined measurement period (almost always 2–3 min) interspersed with regular mixing and reoxygenation of the experimental medium. The reported decrease in oxygen tension is non-linear due to the backflow of oxygen through the polystyrene microplate and into the microchamber. (right) A series of empirically-calibrated calculations by the XF Wave software is required to deconvolute the effect of oxygen backflow and generate quantitative oxygen consumption rates from the reported changes in oxygen tension. (c) Scheme of the XF Analyzer well showing how the amount of oxygen back-diffusion into the well changes with the oxygen consumption rate. As the measurement period proceeds, the difference in oxygen tension between the microchamber and the ambient environment increases, driving more oxygen across the microplate and into the chamber. Oligo,, oligomycin.

In microplate-based platforms, the reported oxygen tension values are non-linear due to back-diffusion of oxygen through the plastic microplate and into the measurement chamber. XF ‘Wave’ software, though, reports quantitative rates after a series of adjustments accounting for several factors and calibration to data from Clark-type electrodes104. The software aims to be user-friendly, enable rapid analysis and iteration, and lower the barrier of entry for those new to the field. As a result, it shields these corrections from the end user.

These adjustments include a correction for the back-diffusion of oxygen into the plate that progressively increases as O2 is depleted in the well. This correction deconvolutes biological oxygen consumption from artifacts arising from the use of a semi-closed system (Figs. 2b,c), and the final rates reported by the instrument (“Rate” tab in Wave software) are comparable to those obtained with Clark-type electrodes104. Rates of oxygen consumption should therefore never be manually calculated from the non-linear decreases in O2 values reported by the XF Analyzer (‘Level” tab in Wave software). The reported [O2] has not undergone the necessary corrections – only the ‘rate’ data is corrected, and in a way that is nonobvious to the user.

Although the rates reported by the XF Analyzer are quantitatively trustworthy across a wide range of values, the gas-impermeable measurement chamber of Clark-type electrodes may provide more reliable measurement of very low oxygen consumption rates (e.g. isolated mitochondria when ADP is depleted21, ATP synthesis is inhibited, or at low O2 levels). As an example, a long-used though arguably limiting measurement of mitochondrial function is the respiratory control ratio (RCR; see Table 2). The XF Analyzer can often overestimate the RCR in a way that is inconsistent with previous literature and can complicate the cross-comparison of current work with historical data39,47. This overestimation is perhaps due to slight inconsistency or inaccuracy when reporting low oxygen consumption rates, such as the State 4o rate, that cause an overestimation of the RCR. Moreover, situations where no appreciable non-mitochondrial respiration is expected still show residual rates upon addition of electron transport chain inhibitors, suggesting very low rates may be quantitatively unreliable in plate-based platforms.

An additional complication unique to microplate-based respirometry stems from varying environmental effects across the multi-well plate when using adherent cell monolayers cultured in humidified CO2 incubators. Cells grown in wells at the outer rim of the microplate are subject to well-documented differences in temperature and humidity gradients that can cause inconsistent data105,106. These temperature and evaporative effects are particularly problematic for cell types that require many days in culture, and in all cases, it is strongly recommended that only the inner 60 wells be used and the outer rim filled with medium or PBS to minimize these effects. This arrangement still allows for 12 experimental groups, each with 5 technical replicates.

Lastly, an arguable strength of chamber-based setups – and even bulk fluorescent dyes – relative to the Seahorse XF Analyzer is that the reported oxygen consumption rate represents all the sample material in the chamber. With the XF Analyzer, cells plated directly under the measurement sensor have a greater contribution to the overall rate relative to those at the periphery of the well93. This may be an issue when studying intact cells, as unevenly distributed cells may increase the data spread between technical replicates, and growing adherent monolayers to near-confluence could affect cell signaling and basal metabolic rates.

DATA ANALYSIS AND INTERPRETATION

GUIDELINES FOR DATA NORMALIZATION

Isolated mitochondria

One advantage of studying respiration in isolated mitochondria compared with cells or tissue is the ease with which data can be meaningfully normalized to total mitochondrial protein content. Each mitochondrial preparation necessarily involves a determination of protein concentration in order to add the appropriate amount to the measurement well or chamber, and the particular detection method (e.g. biuret, Bradford, BCA, etc.) and use of detergents in sample preparation can yield different concentrations. Reporting rates in pmol O or O2/min/μg mitochondrial protein (or nmol O or O2/min/mg) is easy and essential: rates presented this way can indicate the quality of the mitochondrial preparation by comparison with data from other laboratories and previously published work. Indeed, a significant drawback from the use of bulk fluorometric dyes to measure oxygen consumption (e.g. MitoXPress) is that the approach can only measure relative differences without such quantitation107.

As a corollary, scaling rates to “1” or “100%” is frequently unnecessary and can very often be misleading (Figure 3). Overly processed data can hide mitochondrial preparations of poor quality with low respiratory rates or high day-to-day variability. This masking of quantitative rates also makes it difficult to discriminate between effects driven by meaningful biological changes or artifacts of calculation (Figs. 3a, b). Similarly, the RCR is a ratio-based parameter that partially relies on the assumption that mitochondrial dysfunction should decrease the ADP-stimulated rate and increase proton leak-associated respiration. However, this is not always the case, particularly when measuring low rates in microplate-based formats.

Figure 3 -. Importance of analyzing raw, quantitative rates and potential pitfalls of scaling respiration data.

Figure 3 -

(a) A hypothetical example is given where a weak inhibitor of pyruvate dehydrogenase (PDHi) reduces the ADP-stimulated respiration rate relative to vehicle controls in isolated mitochondria offered pyruvate with malate, as shown in both a (left) Clark-type electrode and (middle) Seahorse XF Analyzer. (right) Data normalized to 100% of the vehicle control. Mito., isolated mitochondria; Oligo., oligomycin; PDHi, pyruvate dehydrogenase inhibitor. (b) The same experiment conducted with mitochondria from a suboptimal isolation yields different results. With low rates from damage during the isolation, the effect of PDHi is no longer rate-controlling. Presenting percentage-based data relative to vehicle control shows little difference between groups and the confounding effects of the poor isolation cannot be identified. Abbreviations as before. (c) A hypothetical example is presented of two potential cellular phenotypes that may arise from genetic transformation or pharmacologic intervention. (left) A reduction in ATP demand (blue) lowers the basal rate of respiration but leaves FCCP-stimulated respiration largely unchanged. Additionally, an increase in oxidative capacity (yellow), as can happen with enhanced mitochondrial biogenesis, has little effect on basal respiration but a dramatic effect on the maximal respiration. (right) Calculating the quantitative parameters easily identifies the respective changes. Oligo., oligomycin; Rot/AA, rotenone with antimycin A. (d) Scaling the rates to the initial rate of respiration masks the precise changes, as both present with roughly equal fold-changes in uncoupler-stimulated respiration. Abbreviations as before.

Intact cells

When studying adherent cell monolayers in microplates, normalization of respiration data is one of the most important components of the assay. Genetic interventions or chronic pharmacologic treatments can alter the growth rate of cells in the microplate well, and it is critical to determine if the corresponding changes in the bulk oxygen consumption rate are driven by bioenergetic alterations or merely reflect differences in cell size or number. This is largely not an issue for cellular respiration measured in Clark-type electrode chambers or suspension cells acutely adhered to a microplate well, as a predetermined number of cells are added to the measurement chamber immediately prior to analysis.

Normalizing data to “1” or “100%” is almost always less informative than presenting data in pmol O2/min/1×103 cells, and kinetic traces should never be scaled in this way unless the initial conditions are identical across measurement groups. Internally normalizing data masks excessive day-to-day variability in cell culture preparations and makes it difficult to discern meaningful changes in oxygen consumption from calculation artifacts. This is particularly true for parameters that integrate multiple pieces of information. Scaling these composite parameters to “1” or “100%” further obscures the information obtained and makes it increasingly difficult to define the precise bioenergetic changes between groups, such as whether changes in spare respiratory capacity are primarily driven by altered basal or uncoupler-stimulated respiration rates (Figs. 3c, d).

As with isolated mitochondria, it is also broadly true that the quantitative rates (in pmol O2/min/1×103 cells) can indicate the quality of the cell preparation, particularly with primary cell preparations. However, while results with isolated mitochondria can be compared with historical data spanning decades, oxygen consumption measurements with adherent cell monolayers are far newer by comparison. They may also vary considerably due to different cell culture conditions across laboratories.

Further complications arise from the use of several distinct approaches to scale respiratory data to cell number that make quantitative cross-comparisons difficult. Whenever possible, adherent cell monolayers should be normalized to cell counts obtained with automated digital microscopy and analysis (i.e. high-content image analysis)108. Although these approaches require specialized equipment and training, they provide quantitative readouts with the appropriate resolution. In their absence, cost-effective but less informative approaches have been used such as bulk fluorescence from nuclear stains, total cellular protein, total DNA content, and post hoc cell detachment followed by manual counting with a hemocytometer.

An often-overlooked drawback with non-imaging approaches is their limited sensitivity and linear range of detection. Near-confluent cellular monolayers, as are often suggested with XF Analyzer measurements, very often saturate bulk detection signals or report similar cell densities between groups that may substantially differ. Before any experiment, it is important to determine that the method of normalization can detect subtle differences in cell number (e.g. 10–15%), and does not introduce compounding technical or measurement errors that further cloud interpretation.

Importantly, any normalization parameter used as a surrogate for cell number (i.e. total protein, DNA content, etc.) should be examined in response to the drug treatment or genetic modification under investigation. As an example, loss of the Wolfram Syndrome protein Miner1 causes a substantial expansion in cell size along with an increase in respiratory capacity, cristae density, and mitochondrial Ca2+ storage109. As such, choosing whether to normalize to nuclei or total protein would have profound implications on interpreting the functional consequence of protein ablation.

Cell lifting during the course of the assay may also complicate post hoc normalization efforts, leading to an underestimation of cell number and possible data misinterpretation if an experimental group is differentially susceptible to detachment relative to matched controls. Although there is no perfect solution, several approaches can help such as use of a replicate plate devoted strictly to normalization or conducting cell counts immediately prior to the assay after ensuring the procedure will not affect the functional measurements. Use of a protein- or peptide-based reagent for cell adhesion can be helpful, but use of any plate coating should include a test of whether the adhesive interferes with the normalization method.

3D and multicellular structures

Normalization is one of the bigger challenges when studying respiration in multicellular models and tissue biopsies. For spheroids and other organoids such as pancreatic islets, it is often convenient to present data on a per spheroid/islet basis. However, it is essential that these be controlled for size. Post hoc analysis of cell number, DNA, or protein content after dissociation and sample recovery is a possible solution, though this may compound error in the analysis, especially when needing to dislodge samples from biological adhesives. When possible, tissue samples should be processed with an automated slicer and controlled as best as possible for weight and shape.

The addition of mitochondrial effectors in 3D systems such as oligomycin and FCCP can greatly improve data interpretation. Internally scaled parameters12 [e.g. ratio of basal to maximal respiration, coupling efficiency, etc.] should be mostly avoided when working with isolated mitochondria or intact cells because it is straightforward to appropriately normalize the data and calculate respiratory rates per cell or microgram of mitochondrial protein. However, given the difficulty associated with normalizing oxygen consumption data from multicellular structures, ratio-based parameters can be a useful way to find differences between experimental groups that are independent of amount of sample material loaded.

RECOMMENDATIONS TO IMPROVE DATA REPUTABILITY

Data collection

All oxygen consumption measurements in the Seahorse XF Analyzer should be reported only when the system is at steady-state, i.e. a constant rate. Rates that consistently fluctuate or trail down without settling should be interpreted with ample caution. This could be indicative of sub-optimal sample preparation, low signal-to-noise, or any number of technical issues. For all XF experiments, technical replicates should be examined individually prior to data analysis to ensure there are no injection failures or leakage from the injector ports in any measurement well.

Regardless of the platform or model system used, initial studies should ensure a linear dependence of the oxygen consumption rate on the amount of biological material to identify the appropriate dynamic range for the measurements12. Recommendations for structuring experiments with appropriate biological and technical replicates are given in Box 3.

Box 3: Defining guidelines for biological and technical replicates.

The same guidelines regarding biological and technical replicates and their statistical evaluation for other experiments also apply to oxygen consumption measurements. A mitochondrial isolation or cell preparation from each mouse, or each passage of an immortalized cell line, is generally considered a single biological replicate and should be assessed with sufficient technical replicates. There are unique considerations for each measurement platform.

As chamber-based experiments must be conducted with only one or two runs at a time, potential time-dependent effects from hours-long experimentation should be controlled by mirroring the experimental sequence [e.g. WT1 (replicate 1), KO1, KO2, WT2]. If the amount of material is not sufficient for technical replicates, increasing the number of biological replicates may be required.

Microplate-based respirometry allows simultaneous measurement of several experimental groups, so temporal effects from sample degradation are often not an issue. Despite the increased throughput, it is almost always recommended to spread different biological replicates over multiple days (and XF cartridges) to control for operational and technical inconsistencies. Microplates offer up to 92 simultaneous measurements (a minimum of 4 of 96 wells are needed as background controls) when studying isolated mitochondria or cell suspensions spun onto the plate immediately prior to use. For adherent cell monolayers cultured in humidified CO2 incubators, however, it is recommended that the outer rim be filled with medium or PBS. This mitigates effects from varying temperature or humidity in cells grown at the plate edge105,106, and still accommodates 12 experimental groups with 5 technical replicates per group.

Regardless of the platform, a peer reviewer should be entitled to inquire about the reproducibility of results and request original measurement files during manuscript review.

The quality of any respirometry experiment is largely dictated by the quality of the sample material. When studying isolated mitochondria, isolation protocols have fortunately been established and refined over decades for most rodent tissues21,2630,110. Consulting the established literature prior to beginning work with isolated mitochondria is strongly recommended, as isolations from different tissues frequently require different buffer compositions and centrifugation protocols to optimize function and yield.

Care is required to adhere to seemingly trivial details of the isolation procedure (e.g., keeping sample material near 4°C at all times, routinely checking the pH of isolation buffers, working quickly to extract and mince tissue, disrupting tissue without over- or under-homogenizing the sample, using buffers containing fatty acid-free BSA and chelators of divalent cations, etc.). All efforts should be made to use specialized equipment when disrupting tissue, such as a drill-driven Teflon/PFTE pestle for isolating liver mitochondria or an immersion homogenizer for skeletal muscle mitochondria, as these will significantly improve the yield and quality of the isolation.

The RCR is traditionally used to validate the quality of a mitochondrial preparation, with higher values more indicative of a good preparation. As mentioned previously, however, cross-comparison of data between Clark-type electrodes and XF Analyzers may be problematic as the XF often gives far higher RCR values relative to platinum-based electrodes. Addback of cytochrome c is an additional, platform agnostic functional test for the quality control of a mitochondrial preparation. Exogenously added cytochrome c should not increase the respiratory rate, thereby indicating an intact outer membrane31,111.

When studying intact cells, subtle changes in the day-to-day quality of the cell preparation that may not alter qualitative findings from destructive, end-point assays (e.g. gene or protein expression, metabolomics etc.) are often reflected in measurements of live cell energetics. For primary cell preparations, seemingly minor details (e.g. small changes in the time required for tissue preparations, changing vendors for the protease used for digestion, etc.) can have surprisingly large effects on the respiratory rate. For immortalized cells, variability can be somewhat mitigated by tightly controlling conditions for subculturing and split ratios, passage number, composition of growth medium, and other technical considerations.

With both cells and mitochondria, decisions that balance sample purity and yield often have functional consequences for respirometry assays. For example, the purity of mitochondrial preparations can be increased by gradient purification (e.g. use of a Percoll gradient to isolate brain mitochondria). However, this increased homogeneity often comes not only with lower yields but also poorer quality data relative to conventional isolations. Similarly, respiration in whole cells is also frequently impaired after purification procedures such as isolation of specific cell populations with flow cytometry that can take hours, and day-to-day inconsistencies of the purifications can cause prohibitive variability in results.

As mentioned previously, the Seahorse XF Analyzer software reports oxygen consumption rates after an opaque correction for several factors including back-diffusion of oxygen from the ambient environment into the measurement microchamber. An additional complication with this automated calculation stems from the requirement that the measurement period be at least two minutes long (the default setting is three minutes) with measurements of oxygen tension taken at 15 second intervals. When respiration rates are very high, the oxygen in the microchamber can be depleted before the measurement time is completed, and the very low [O2] can be limiting for the respiratory rate. This anoxia in the instrument microchamber prior to the end of the measurement period causes the instrument to report artifactually low rates due to oxygen depletion, and can lead to gross data misinterpretation (Figure 4).

Figure 4 -. Anoxia in the XF microchamber with high respiratory rates causes severe calculation artifacts.

Figure 4 -

(a) At very high respiration rates – as can happen during uncoupler-stimulated respiration in metabolically active cells such as neurons, myocytes, or brown adipocytes – lack of oxygen in the XF measurement well can cause artifacts of calculation. In the hypothetical example, too much isolated mitochondria is loaded into the XF measurement well. Upon addition of ADP, so much oxygen is depleted during the measurement time (minimum of 2 min.) that oxygen availability limits the respiratory rate. The limited O2 availability and increased back-diffusion of oxygen into the microplate exaggerates the non-linearity of the observed rate. (b) (top) The XF Wave software uses a composite of the point-to-point rates – calculated from the readings at 15-second intervals shown as squares in (a) – to report the oxygen consumption rate. If the microchamber becomes anoxic, the instrument will report artificially low rates by aggregating the low rates observed during anoxia into the overall average. Artifacts, such as the rate of respiration being roughly similar in the presence or absence of oligomycin, can occur. (bottom) Checking the stability of point-to-point rates in the software, as well as observing the oxygen tension levels themselves, can determine whether lack of oxygen availability is an issue during an assay.

Microchamber anoxia should be controlled for whenever initially optimizing respirometry with isolated mitochondria. Mitochondria isolated from different tissues will inevitably have varying oxidative capacities, so each experiment should begin with a titration to find an appropriate concentration of mitochondria that gives a robust signal while avoiding anoxia21. For example, mitochondria isolated from liver have a lower maximal oxidative capacity for pyruvate/malate than those isolated from heart or brain, and will require more mitochondria in the microplate well. Additionally, respiratory rates will vary considerably based on the substrate provided, particularly for TMPD with ascorbate (for isolated complex IV activity where respiratory rates should be much higher than complex I- or II-linked substrates). Tips to avoid microchamber anoxia and generating reliable data include adjusting the sample material loaded based on the substrate provided and reducing the measurement time to two minutes.

Although less frequently an issue when studying intact cells, anoxia in the XF Analyzer measurement well can affect measurements of maximal, uncoupler-stimulated respiration. This often occurs with terminally differentiated cells characterized by a high oxidative capacity such as neurons, cardiomyocytes, or brown adipocytes, though the O2 levels should be checked when working with all cell types. Although the XF24 well plate offers a greater microchamber volume, this does not necessarily minimize the risk of anoxia because it is offset by the increased surface area accommodating more material.

Oxygen depletion during XF measurements well should be checked whenever obtaining rates above 500 pmol O2/min in the 8- or 96-well platforms or rates above 1500 pmol O2/min in the larger 24-well platform by examining the “Level” option in the XF Wave software. For cells with high respiratory capacities and relatively low basal rates, it may be challenging to find a cell density which yields suitably high inital rates without depleting oxygen when measuring uncoupler-stimulated respiration. In general, an ideal range for initial oxygen consumption rates are around 75–150 pmol O2/min but are generally trustworthy above 50 pmol O2/min if lower density is required to avoid microchamber anoxia upon addition of FCCP.

When using microplate-based platforms, especially with intact cells or 3D multicellular structures, it is essential to correct all rates for non-mitochondrial respiration and background signal from the instrument by inhibiting the respiratory chain. This is typically done with the complex I inhibitor rotenone and the complex III inhibitor antimycin A. A substantive portion of the initial respiratory rate in whole cells (often 20–35%) is insensitive to respiratory chain inhibition in the XF Analyzer, so correcting for this has a meaningful impact on the reported rates of basal and maximal respiration. The values obtained from the XF Analyzer contrast previous measurements that 90–95% of cellular oxygen consumption is mitochondrial112, suggesting some component of the ‘non-mitochondrial’ oxygen consumption rate is instrument background.

As a result, interpreting ‘non-mitochondrial’ rates of respiration is generally only relevant in cells which express abundant amounts of non-mitochondrial oxidases such as the NADPH oxidase. Assessing activity of these enzymes by respirometry can be done with appropriate controls such as activation with phorbol esters and inhibition of NADPH-supported non-mitochondrial oxygen consumption by flavin-targeted compounds such as DPI113. In cultured cells, excessively high rates of respiration insensitive to electron transport chain inhibition may indicate contamination with mycoplasma or other bacteria.

Work with 3D structures seeded onto layers of basement membrane mixtures like Matrigel are perhaps more susceptible to high or artificial background signals, which could be due to altered rates of diffusion across the bottom of the microplate compared against the conditions where the algorithm was calibrated12,104. An additional complication for adding exogenous effectors to multicellular model systems is that differently sized spheroids, organoids, or tissue pieces will likely exhibit different kinetic responses to drugs and mitochondrial effectors. For all measurement platforms, the timing protocols for assays should be empirically determined to ensure enough time has elapsed for the system to reach a new respiratory steady state in response to compound addition. This is particularly important for bulky compounds such as oligomycin that may have kinetic limitations for its diffusion into the core of a 3D structure.

Calculation of respiratory parameters

When working with isolated mitochondria, the most informative respiratory parameters are often oxygen consumption stimulated by ADP phosphorylation (State 3) or an uncoupler such as FCCP or Bam15 (uncoupled or State 3u), as well as oxygen consumption linked to proton leak (State 4; see Table 2). It is recommended that the RCR not be presented unless alongside the State 3 and State 4 rates that comprise this ratio. Terms such as basal respiration and spare respiratory capacity, frequently used when studying cell-based systems, are inappropriate when studying isolated mitochondria. These parameters are only informative when considering the energy demand and rate of ATP utilization in intact, live cells, and are therefore meaningless in reductionist systems offered excess ADP.

Respiratory rates in isolated mitochondria should be measured on multiple oxidizable substrates whenever possible. Examining distinct oxidative pathways (e.g. respiration supported by pyruvate/malate, glutamate/malate, succinate/rotenone, ascorbate/TMPD, etc.) helps pinpoint differences between experimental groups29. Additionally, these data can also be helpful for judging the quality of a mitochondrial preparation. For example, the relative rates of NADH- vs. QH2-linked substrates could indicate whether complex I was damaged during the mitochondrial isolation.

Interpreting respirometry data in cells and 3D models involves an additional layer of complexity compared to isolated mitochondria or permeabilized cells: the basal rate of oxygen consumption largely reflects the cellular rate of ATP utilization, rather than the capacity for oxidation of energy substrates. As a result, increases or decreases in basal respiration do not necessarily reflect improvements or defects in mitochondrial function18. For example, a reduction in basal respiration between measurement groups could simply indicate a reduced energy demand in the cell rather than a catabolic defect.

Similarly, an increased basal oxygen consumption between groups may indicate a compensatory response to stress, highlighting the need to interpret basal respiratory rates alongside uncoupler-stimulated rates of respiration that disengage respiratory chain activity from cellular ATP requirements. Figure 5 highlights common phenotypes obtained with intact cell respirometry along with broad guidelines for follow up studies. Box 4 provides additional, specific guidance to determine if changes in proton leak-linked respiration are due to direct alterations in proton permeability of the inner membrane or indirect effects from changes in mitochondrial oxidative capacity.

Figure 5 -. Common phenotypes observed during intact cell respirometry and their interpretations.

Figure 5 -

A description of common phenotypes is given along with their most likely interpretations and suggestions for follow-up experiments with permeabilized cell respirometry. Representative results are presented in the format of Seahorse XF Analyzer kinetic traces for changes in (a) cellular energy demand, (b) substrate transport or oxidation, (c) cell number, or (d) mitochondrial uncoupling. Additionally, examples of common technical problems, and a representative trace, is given in (e). O, oligomycin; F, FCCP; RA, rotenone with antimycin A.

Box 4: Revealing mechanisms of proton leak and altered energy expenditure with respirometry.

There is considerable interest in using oxygen consumption rates as a primary method to identify molecular mechanisms of mitochondrial uncoupling. Respiration linked to mitochondrial proton leak (oxygen consumption in the absence of ATP synthesis; termed ‘State 4’ in isolated mitochondria) is indeed a useful measurement for determining an uncoupling effect. The measurements can reveal genetic pathways or identify pharmacologic compounds that alter the efficiency of mitochondrial energy transduction and even increase whole body energy expenditure through mechanisms such as brown adipose tissue thermogenesis.

In this context, however, it is important to distinguish whether interventions that change proton leak-linked respiration are either (1) direct, genuine changes in proton permeability of the mitochondrial inner membrane, or rather (2) indirect changes in proton leak as a consequence of increased mitochondrial oxidative capacity. This concept is discussed in theory elsewhere12,66. As a general, practical principle, if proton leak-associated respiration increases but the FCCP-stimulated rate remains unchanged (or is even reduced), then the primary change is likely attributable to increased inner membrane proton conductance. However, if the uncoupler-stimulated respiration rate changes alongside the proton leak rate, the phenotype is likely driven by changes in mitochondrial substrate oxidation and the changes in uncoupling are a secondary consequence.

In addition to directly measuring membrane conductance with patch clamp electrophysiology of mitoplasts128, genuine effects of changes in proton permeability in isolated mitochondria can be assessed by simultaneous measurement of State 4 respiration with the mitochondrial membrane potential. This is readily done in chamber-based setups, but can also be conducted with parallel measurements in microplates. In intact cells, the same principle largely holds, though quantitative measurement of the membrane potential is exceedingly specialized129. As such, internally normalized parameters identifying the fraction of the total basal respiratory rate that supports ATP synthesis (coupling efficiency) or the ratio of FCCP-stimulated respiration to proton leak respiration (cell respiratory control ratio) may be useful in this specific instance.

Importantly, interpretations of spare respiratory capacity should be viewed in light of the model system used. The calculation is a useful construct to study cells such as myocytes or neurons: differentiated, electrically excitable cells where the resting in vitro respiratory rates are low in the absence of a physiological stimulus and do not reflect the periodic, maximal energy demands experienced in vivo58. It has also be applied primary T cells, where maximal rates of respiration may better reflect the capacity to support the energetic and biosynthetic demands of cell activation rather than in vitro, basal rates114. However, interpretations of spare respiratory capacity in cancer cells or other proliferating cell models are less clear, as changes in the basal respiratory rates set by the energy demands of cell division and anabolism may be lost or misinterpreted12,16. Regardless of the model system, it is impossible to directly identify molecular mechanisms of action by calculating spare respiratory capacity as it integrates multiple experimental parameters.

Data presentation

For all model systems and experimental platforms, it is highly recommended to include at least one representative kinetic trace comparing the most relevant experimental groups in addition to bar charts or scatter plots of aggregated biological replicates. This fosters confidence that calculated respiratory parameters are derived from trustworthy data. For the XF Analyzer, it may be appropriate for peer reviewers to also ask for multiple kinetic traces and even the O2 levels underlying the data. These may be particularly important if there are concerns that data interpretation is confounded by oxygen limitation in the measurement well or other calculation artifacts.

Every effort should be made to report quantitative, appropriately normalized respiratory rates to allow cross-comparison with other laboratories and historical data (i.e. pmol O2/min/μg mitochondrial protein for isolated mitochondria or pmol O2/min/1×103 cells). Quantitative, ‘raw’ rates should always be provided alongside when scaling rates to 1 or 100%, as is often done with concentration-response curves for drugs relative to a vehicle control.

When studying intact cells with the XF Analyzer, it may be helpful to include basal rates of extracellular acidification alongside respiration data even if there is no consideration of glycolysis. This can aid interpretation as to whether altered oxygen consumption rates are due to a global change in energy demand, a shift in the balance between oxidative phosphorylation and glycolysis, or technical issues with the experiment that may present in both readouts such as cells lifting from the plate. Recent adjustments to account for respiratory acidification allow accurate measurements of lactate efflux and estimates of the cellular ATP production rate93,94, which can help further distinguish between healthy energetic adaptation or bioenergetic dysfunction.

CONCLUSION

These recommendations are not meant to be pedantic or exclusionary, but rather to improve data consistency and reproducibility across laboratories. For example, a drug candidate or genetic intervention that may weakly, but meaningfully, reduce complex I activity would present very differently in mitochondria from a well-executed isolation with robust oxygen consumption rates compared to a poor isolation. Or, when an observed change in spare respiratory capacity cannot be reproduced, it may be important to determine whether the primary driver of the discrepancy is a change in the basal or maximal respiratory rates to identify the underlying cause. As such, we seek to assist with experimental design and warn of common pitfalls regarding data analysis and interpretation. Additionally, we attempt to merge the transparency and rigor of traditional bioenergetic analyses with the physiological relevance and practicality of current metabolic studies.

The importance of a shared set of best practices is highlighted by the advancing clinical studies targeting metabolism115,116, and the potential for respirometry to monitor disease states and target engagement. There are also remains a large fraction of unannotated mitochondrial proteins117, and oxygen consumption can be an important tool in defining the function of these proteins that may to rewrite our textbook understanding of this organelle89,118,119. Methodologically, the field will inevitably address the challenges associated with conducting respirometry under environmental control and in 3D models and tissue biopsies given our growing appreciation for how the surrounding microenvironment can control metabolism. As progress in metabolic and bioenergetic research is likely to continue at a breakneck pace, establishing a well-accepted set of ground rules for data normalization, analysis, and interpretation of oxygen consumption measurements will be essential to move the field forward.

ACKNOWLEDGEMENTS

ASD is supported by National Institutes of Health Grants R35GM138003, P30DK063491, and P50CA092131, as well as the W.M. Keck Foundation. MJ is supported by the Novo Nordisk Research Fonden (NNF20OC0059646). We would like to thank members of both of our laboratories for their helpful discussions during the preparation of this manuscript, as well as Linsey Stiles (UCLA), Brandon Desousa (UCSF), and Anne Murphy (Cytokinetics, Inc.) for their critical perspective.

ABBREVIATIONS

FCCP

Carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone

ROS

reactive oxygen species

DNP

2,4-dinitrophenol

TMPD

N,N,N’,N’-tetramethyl-p-phenylenediamine

Footnotes

COMPETING INTERESTS

The authors declare no current competing interests. ASD has previously served as a paid consultant for Agilent Technologies.

REFERENCES

  • 1.Pagliarini DJ & Rutter J. Hallmarks of a new era in mitochondrial biochemistry. Genes and Development vol. 27 2615–2627 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Viale A. et al. Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function. Nature 514, 628–632 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Huang SCC et al. Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages. Nat. Immunol (2014) doi: 10.1038/ni.2956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Tannahill GM et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature (2013) doi: 10.1038/nature11986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Choi SW, Gerencser AA & Nicholls DG Bioenergetic analysis of isolated cerebrocortical nerve terminals on a microgram scale: Spare respiratory capacity and stochastic mitochondrial failure. J. Neurochem (2009) doi: 10.1111/j.1471-4159.2009.06055.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Gubser PM et al. Rapid effector function of memory CD8+ T cells requires an immediate-early glycolytic switch. Nat. Immunol 14, 1064–1072 (2013). [DOI] [PubMed] [Google Scholar]
  • 7.Chandel NS Evolution of Mitochondria as Signaling Organelles. Cell Metabolism (2015) doi: 10.1016/j.cmet.2015.05.013. [DOI] [PubMed] [Google Scholar]
  • 8.Murphy MP & Hartley RC Mitochondria as a therapeutic target for common pathologies. Nature Reviews Drug Discovery (2018) doi: 10.1038/nrd.2018.174. [DOI] [PubMed] [Google Scholar]
  • 9.Pelletier M, Billingham LK, Ramaswamy M. & Siegel RM Extracellular flux analysis to monitor glycolytic rates and mitochondrial oxygen consumption. in Methods in Enzymology (2014). doi: 10.1016/B978-0-12-416618-9.00007-8. [DOI] [PubMed] [Google Scholar]
  • 10.Mitchell P. Chemiosmotic coupling in oxidative and photosynthetic phosphorylation. Biochimica et Biophysica Acta - Bioenergetics vol. 1807 1507–1538 (2011). [DOI] [PubMed] [Google Scholar]
  • 11.Nicholls DG & Ferguson SJ Bioenergetics 4. Academic ORess (2013). doi: 10.1017/CBO9781107415324.004. [DOI] [Google Scholar]
  • 12.Divakaruni AS, Paradyse A, Ferrick DA, Murphy AN & Jastroch M. Analysis and interpretation of microplate-based oxygen consumption and pH data. in Methods in Enzymology (2014). doi: 10.1016/B978-0-12-801415-8.00016-3. [DOI] [PubMed] [Google Scholar]
  • 13.Doerrier C. et al. High-resolution fluorespirometry and oxphos protocols for human cells, permeabilized fibers from small biopsies of muscle, and isolated mitochondria. in Methods in Molecular Biology (2018). doi: 10.1007/978-1-4939-7831-1_3. [DOI] [PubMed] [Google Scholar]
  • 14.Will Y, Hynes J, Ogurtsov VI & Papkovsky DB Analysis of mitochondrial function using phosphorescent oxygen-sensitive probes. Nat. Protoc (2007) doi: 10.1038/nprot.2006.351. [DOI] [PubMed] [Google Scholar]
  • 15.Perry CGR, Kane DA, Lanza IR & Neufer PD Methods for assessing mitochondrial function in diabetes. Diabetes (2013) doi: 10.2337/db12-1219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Schmidt CA, Fisher-Wellman KH & Neufer PD From OCR and ECAR to energy: Perspectives on the design and interpretation of bioenergetics studies. J. Biol. Chem 297, 101140 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Brand MD & Nicholls DG Assessing mitochondrial dysfunction in cells. Biochemical Journal (2011) doi: 10.1042/BJ20110162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Jones AE et al. Forces, fluxes, and fuels: Tracking mitochondrial metabolism by integrating measurements of membrane potential, respiration, and metabolites. Am. J. Physiol. - Cell Physiol 320, C80–C91 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Connolly NMC et al. Guidelines on experimental methods to assess mitochondrial dysfunction in cellular models of neurodegenerative diseases. Cell Death Differ. (2018) doi: 10.1038/s41418-017-0020-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Dranka BP, Hill BG & Darley-Usmar VM Mitochondrial reserve capacity in endothelial cells: The impact of nitric oxide and reactive oxygen species. Free Radic. Biol. Med (2010) doi: 10.1016/j.freeradbiomed.2010.01.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Rogers GW et al. High throughput microplate respiratory measurements using minimal quantities of isolated mitochondria. PLoS One (2011) doi: 10.1371/journal.pone.0021746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Divakaruni AS, Rogers GW & Murphy AN Measuring mitochondrial function in permeabilized cells using the seahorse XF analyzer or a clark-type oxygen electrode. Curr. Protoc. Toxicol (2014) doi: 10.1002/0471140856.tx2502s60. [DOI] [PubMed] [Google Scholar]
  • 23.Hynes J, Swiss RL & Will Y. High-throughput analysis of mitochondrial oxygen consumption. in Methods in Molecular Biology (2018). doi: 10.1007/978-1-4939-7831-1_4. [DOI] [PubMed] [Google Scholar]
  • 24.Acin-Perez R, Benincá C, Shabane B, Shirihai OS & Stiles L. Utilization of Human Samples for Assessment of Mitochondrial Bioenergetics: Gold Standards, Limitations, and Future Perspectives. Life 11, (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Hill BG et al. Integration of cellular bioenergetics with mitochondrial quality control and autophagy. Biol. Chem 393, 1485–1512 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Frezza C, Cipolat S. & Scorrano L. Organelle isolation: Functional mitochondria from mouse liver, muscle and cultured filroblasts. Nat. Protoc 2, 287–295 (2007). [DOI] [PubMed] [Google Scholar]
  • 27.Wieckowski MRMR, Giorgi C, Lebiedzinska M, Duszynski J. & Pinton P. Isolation of mitochondria-associated membranes and mitochondria from animal tissues and cells. Nat. Protoc 4, 1582–1590 (2009). [DOI] [PubMed] [Google Scholar]
  • 28.Kushnareva YE, Wiley SE, Ward MW, Andreyev AY & Murphy AN Excitotoxic injury to mitochondria isolated from cultured neurons. J. Biol. Chem 280, 28894–28902 (2005). [DOI] [PubMed] [Google Scholar]
  • 29.Yang K, Doan MT, Stiles L. & Divakaruni AS Measuring CPT-1-mediated respiration in permeabilized cells and isolated mitochondria. STAR Protoc. 2, (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Benador IY et al. Mitochondria Bound to Lipid Droplets Have Unique Bioenergetics, Composition, and Dynamics that Support Lipid Droplet Expansion. Cell Metab. 27, 869–885.e6 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Divakaruni AS et al. Thiazolidinediones are acute, specific inhibitors of the mitochondrial pyruvate carrier. Proc. Natl. Acad. Sci. U. S. A (2013) doi: 10.1073/pnas.1303360110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Salabei JK, Gibb AA & Hill BG Comprehensive measurement of respiratory activity in permeabilized cells using extracellular flux analysis. Nat. Protoc (2014) doi: 10.1038/nprot.2014.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Quintana A, Kruse SE, Kapur RP, Sanz E. & Palmiter RD Complex I deficiency due to loss of Ndufs4 in the brain results in progressive encephalopathy resembling Leigh syndrome. Proc. Natl. Acad. Sci. U. S. A 107, 10996–11001 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Rich PR & Maréchal A. The mitochondrial respiratory chain. Essays Biochem. (2010) doi: 10.1042/BSE0470001. [DOI] [PubMed] [Google Scholar]
  • 35.Kiss G. et al. The negative impact of α-ketoglutarate dehydrogenase complex deficiency on matrix substrate-level phosphorylation. FASEB J. 27, 2393–2406 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Ryan DG et al. Coupling Krebs cycle metabolites to signalling in immunity and cancer. Nat. Metab (2019) doi: 10.1038/s42255-018-0014-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Gray LR et al. Hepatic Mitochondrial Pyruvate Carrier 1 Is Required for Efficient Regulation of Gluconeogenesis and Whole-Body Glucose Homeostasis. Cell Metab. 22, 669–681 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Taylor EB Functional Properties of the Mitochondrial Carrier System. Trends in Cell Biology (2017) doi: 10.1016/j.tcb.2017.04.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Woodall BP et al. Parkin does not prevent accelerated cardiac aging in mitochondrial DNA mutator mice. JCI Insight 4, (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Norton M. et al. ROMO1 is an essential redox-dependent regulator of mitochondrial dynamics. Sci. Signal 7, (2014). [DOI] [PubMed] [Google Scholar]
  • 41.Fu Z. et al. Requirement of Mitochondrial Transcription Factor A in Tissue-Resident Regulatory T Cell Maintenance and Function. Cell Rep. 28, 159–171.e4 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Pagliarini DJ et al. Involvement of a Mitochondrial Phosphatase in the Regulation of ATP Production and Insulin Secretion in Pancreatic β Cells. Mol. Cell 19, 197–207 (2005). [DOI] [PubMed] [Google Scholar]
  • 43.Wang G. et al. Modeling the mitochondrial cardiomyopathy of Barth syndrome with iPSC and heart-on-chip technologies. Nat. Med 20, 616 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Leonardi R, Zhang YM, Rock CO & Jackowski S. Coenzyme A: Back in action. Progress in Lipid Research (2005) doi: 10.1016/j.plipres.2005.04.001. [DOI] [PubMed] [Google Scholar]
  • 45.Solmonson A. & DeBerardinis RJ Lipoic acid metabolism and mitochondrial redox regulation. J. Biol. Chem 293, 7522 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Stefely JA & Pagliarini DJ Biochemistry of Mitochondrial Coenzyme Q Biosynthesis. Trends Biochem. Sci 42, 824–843 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Daan Westenbrink B. et al. Mitochondrial Reprogramming induced by CaMKIIδmediates hypertrophy decompensation. Circ. Res 116, e28–e39 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Rotig A. et al. Aconitase and mitochondrial iron–sulphur protein deficiency in Friedreich ataxia. Nat. Genet 1997 172 17, 215–217 (1997). [DOI] [PubMed] [Google Scholar]
  • 49.Diers AR, Broniowska KA, Chang CF, Hill RB & Hogg N. S-nitrosation of monocarboxylate transporter 1: Inhibition of pyruvate-fueled respiration and proliferation of breast cancer cells. Free Radic. Biol. Med 69, 229–238 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.CHANCE B. & WILLIAMS GR Respiratory enzymes in oxidative phosphorylation. III. The steady state. J. Biol. Chem 217, 409–427 (1955). [PubMed] [Google Scholar]
  • 51.Estabrook RW [7] Mitochondrial respiratory control and the polarographic measurement of ADP : O ratios. Methods Enzymol. 10, 41–47 (1967). [Google Scholar]
  • 52.Ernster L. & Schatz G. Mitochondria: A historical review. Journal of Cell Biology vol. 91 (1981). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Lopaschuk GD, Karwi QG, Tian R, Wende AR & Abel ED Cardiac Energy Metabolism in Heart Failure. Circ. Res 128, 1487–1513 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Sun H. & Wang Y. Branched chain amino acid metabolic reprogramming in heart failure. Biochim. Biophys. Acta - Mol. Basis Dis 1862, 2270–2275 (2016). [DOI] [PubMed] [Google Scholar]
  • 55.White PJ & Newgard CB Branched-chain amino acids in disease. Science vol. 363 582–583 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Picard M. et al. Mitochondrial structure and function are disrupted by standard Isolation methods. PLoS One 6, (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Arruda AP et al. Chronic enrichment of hepatic endoplasmic reticulum-mitochondria contact leads to mitochondrial dysfunction in obesity. Nat. Med 20, 1427–1435 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Nicholls DG Spare respiratory capacity, oxidative stress and excitotoxicity. Biochem. Soc. Trans (2009) doi: 10.1042/BST0371385. [DOI] [PubMed] [Google Scholar]
  • 59.Adhihetty PJ et al. The role of PGC-1α on mitochondrial function and apoptotic susceptibility in muscle. Am. J. Physiol. - Cell Physiol 297, (2009). [DOI] [PubMed] [Google Scholar]
  • 60.Agier V. et al. Defective mitochondrial fusion, altered respiratory function, and distorted cristae structure in skin fibroblasts with heterozygous OPA1 mutations. Biochim. Biophys. Acta - Mol. Basis Dis 1822, 1570–1580 (2012). [DOI] [PubMed] [Google Scholar]
  • 61.Clerc P. & Polster BM Investigation of mitochondrial dysfunction by sequential microplate-based respiration measurements from intact and permeabilized neurons. PLoS One 7, (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Schulz I. Permeabilizing cells: Some methods and applications for the study of intracellular processes. Methods Enzymol. 192, 280–300 (1990). [DOI] [PubMed] [Google Scholar]
  • 63.Buescher JM et al. A roadmap for interpreting 13 C metabolite labeling patterns from cells. Current Opinion in Biotechnology (2015) doi: 10.1016/j.copbio.2015.02.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Jang C, Chen L. & Rabinowitz JD Metabolomics and Isotope Tracing. Cell (2018) doi: 10.1016/j.cell.2018.03.055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Antoniewicz MR A guide to 13C metabolic flux analysis for the cancer biologist. Experimental and Molecular Medicine (2018) doi: 10.1038/s12276-018-0060-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Divakaruni AS & Brand MD The regulation and physiology of mitochondrial proton leak. Physiology (Bethesda, Md.) (2011) doi: 10.1152/physiol.00046.2010. [DOI] [PubMed] [Google Scholar]
  • 67.Bertholet AM & Kirichok Y. Mitochondrial H + Leak and Thermogenesis. Annu. Rev. Physiol 84, 381–407 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Duchen MR Ca(2+)-dependent changes in the mitochondrial energetics in single dissociated mouse sensory neurons. Biochem. J 283, 41 (1992). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.De Stefani D, Rizzuto R. & Pozzan T. Enjoy the Trip: Calcium in Mitochondria Back and Forth. 10.1146/annurev-biochem-060614-034216 85, 161–192 (2016). [DOI] [PubMed]
  • 70.Villalobo A. & Lehninger AL Inhibition of oxidative phosphorylation in ascites tumor mitochondria and cells by intramitochondrial Ca2+. J. Biol. Chem 255, 2457–2464 (1980). [PubMed] [Google Scholar]
  • 71.Murphy AN, Bredesen DE, Cortopassi G, Wang E. & Fiskum G. Bcl-2 potentiates the maximal calcium uptake capacity of neural cell mitochondria. Proc. Natl. Acad. Sci. U. S. A 93, 9893–9898 (1996). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Veliova M. et al. Blocking mitochondrial pyruvate import in brown adipocytes induces energy wasting via lipid cycling. EMBO Rep. 21, (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Gross MI et al. Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer. Mol. Cancer Ther 13, 890–901 (2014). [DOI] [PubMed] [Google Scholar]
  • 74.Leek R, Grimes DR, Harris AL & McIntyre A. Methods: Using three-dimensional culture (spheroids) as an in vitro model of tumour hypoxia. Adv. Exp. Med. Biol 899, 167–196 (2016). [DOI] [PubMed] [Google Scholar]
  • 75.Simian M. & Bissell MJ Organoids: A historical perspective of thinking in three dimensions. J. Cell Biol 216, 31–40 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.De Graaf IAM et al. Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies. Nature Protocols vol. 5 1540–1551 (2010). [DOI] [PubMed] [Google Scholar]
  • 77.Lau AN & Vander Heiden MG Metabolism in the Tumor Microenvironment. Annual Review of Cancer Biology vol. 4 17–40 (2020). [Google Scholar]
  • 78.Kanow MA et al. Biochemical adaptations of the retina and retinal pigment epithelium support a metabolic ecosystem in the vertebrate eye. Elife 6, (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Harada AE, Healy TM & Burton RS Variation in thermal tolerance and its relationship to mitochondrial function across populations of Tigriopus Californicus. Front. Physiol 10, 213 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Luz AL, Smith LL, Rooney JP & Meyer JN Seahorse XFe24 extracellular flux analyzer-based analysis of cellular respiration in caenorhabditis elegans. Curr. Protoc. Toxicol 66, 25.7.1–25.7.15 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Lay S, Sanislav O, Annesley SJ & Fisher PR Mitochondrial stress tests using seahorse respirometry on intact Dictyostelium discoideum cells. in Methods in Molecular Biology vol. 1407 41–61 (Methods Mol Biol, 2016). [DOI] [PubMed] [Google Scholar]
  • 82.Muthusamy T. et al. Serine restriction alters sphingolipid diversity to constrain tumour growth. Nature 586, 790–795 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Jiang L. et al. Reductive carboxylation supports redox homeostasis during anchorage-independent growth. Nature 532, 255–258 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Tschöp MH et al. A guide to analysis of mouse energy metabolism. Nature Methods vol. 9 57–63 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Müller TD, Klingenspor M. & Tschöp MH Revisiting energy expenditure: how to correct mouse metabolic rate for body mass. Nature Metabolism vol. 3 1134–1136 (2021). [DOI] [PubMed] [Google Scholar]
  • 86.Tyrrell DJ et al. Blood-cell bioenergetics are associated with physical function and inflammation in overweight/obese older adults. Exp. Gerontol 70, 84–91 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Kenwood BM et al. Identification of a novel mitochondrial uncoupler that does not depolarize the plasma membrane. Mol. Metab 3, 114–123 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Davila A. et al. Nicotinamide adenine dinucleotide is transported into mammalian mitochondria. Elife 7, (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Luongo TS et al. SLC25A51 is a mammalian mitochondrial NAD+ transporter. Nature 588, 174–179 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Affourtit C. & Brand MD Stronger control of ATP/ADP by proton leak in pancreatic β-cells than skeletal muscle mitochondria. Biochem. J (2006) doi: 10.1042/BJ20051280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Krasnikov BF et al. Comparative kinetic analysis reveals that inducer-specific ion release precedes the mitochondrial permeability transition. Biochim. Biophys. Acta - Bioenerg 1708, 375–392 (2005). [DOI] [PubMed] [Google Scholar]
  • 92.Mookerjee SA, Goncalves RLS, Gerencser AA, Nicholls DG & Brand MD The contributions of respiration and glycolysis to extracellular acid production. Biochim. Biophys. Acta 1847, 171–181 (2015). [DOI] [PubMed] [Google Scholar]
  • 93.Desousa BR et al. Calculating ATP production rates from oxidative phosphorylation and glycolysis during cell activation. bioRxiv 2022.04.16.488523 (2022) doi: 10.1101/2022.04.16.488523. [DOI] [Google Scholar]
  • 94.Mookerjee SA, Gerencser AA, Nicholls DG & Brand MD Quantifying intracellular rates of glycolytic and oxidative ATP production and consumption using extracellular flux measurements. J. Biol. Chem (2017) doi: 10.1074/jbc.M116.774471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Divakaruni AS, Andreyev AY, Rogers GW & Murphy AN In situ measurements of mitochondrial matrix enzyme activities using plasma and mitochondrial membrane permeabilization agents. Anal. Biochem 552, 60–65 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Divakaruni AS et al. Inhibition of the mitochondrial pyruvate carrier protects from excitotoxic neuronal death. J. Cell Biol (2017) doi: 10.1083/jcb.201612067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Grassian AR, Metallo CM, Coloff JL, Stephanopoulos G. & Brugge JS Erk regulation of pyruvate dehydrogenase flux through PDK4 modulates cell proliferation. Genes Dev. 25, 1716–1733 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.Sullivan WJ et al. Extracellular Matrix Remodeling Regulates Glucose Metabolism through TXNIP Destabilization. Cell 175, 117–132.e21 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99.Sessions AO et al. Preserved cardiac function by vinculin enhances glucose oxidation and extends health- and life-span. APL Bioeng. 2, (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Fan YY et al. A bioassay to measure energy metabolism in mouse colonic crypts, organoids, and sorted stem cells. Am. J. Physiol. - Gastrointest. Liver Physiol 309, (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.Taddeo EP et al. Individual islet respirometry reveals functional diversity within the islet population of mice and human donors. Mol. Metab 16, 150–159 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102.Kooragayala K. et al. Quantification of oxygen consumption in retina ex vivo demonstrates limited reserve capacity of photoreceptor mitochondria. Investig. Ophthalmol. Vis. Sci 56, 8428–8436 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103.Ludikhuize MC, Meerlo M, Burgering BMT & Rodríguez Colman MJ Protocol to profile the bioenergetics of organoids using Seahorse. STAR Protoc. 2, (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 104.Gerencser AA et al. Quantitative microplate-based respirometry with correction for oxygen diffusion. Anal. Chem (2009) doi: 10.1021/ac900881z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 105.Oliver DG, Sanders AH, Douglas Hogg R. & Woods Hellman J. Thermal gradients in microtitration plates. Effects on enzyme-linked immunoassay. J. Immunol. Methods 42, 195–201 (1981). [DOI] [PubMed] [Google Scholar]
  • 106.Lundholt BK, Scudder KM & Pagliaro L. A simple technique for reducing edge effect in cell-based assays. J. Biomol. Screen 8, 566–570 (2003). [DOI] [PubMed] [Google Scholar]
  • 107.Schoonen WGEJ, Stevenson JCR, Westerink WMA & Horbach GJ Cytotoxic effects of 109 reference compounds on rat H4IIE and human HepG2 hepatocytes. III: Mechanistic assays on oxygen consumption with MitoXpress and NAD(P)H production with Alamar BlueTM. Toxicol. Vitr 26, 511–525 (2012). [DOI] [PubMed] [Google Scholar]
  • 108.Little AC et al. High-content fluorescence imaging with the metabolic flux assay reveals insights into mitochondrial properties and functions. Commun. Biol 3, (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 109.Wiley SE et al. Wolfram Syndrome protein, Miner1, regulates sulphydryl redox status, the unfolded protein response, and Ca2+ homeostasis. EMBO Mol. Med 5, 904–918 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110.Wettmarshausen J. & Perocchi F. Isolation of functional mitochondria from cultured cells and mouse tissues. Methods Mol. Biol 1567, 15–32 (2017). [DOI] [PubMed] [Google Scholar]
  • 111.Kirkinezos IG et al. Cytochrome c Association with the Inner Mitochondrial Membrane Is Impaired in the CNS of G93A-SOD1 Mice. J. Neurosci 25, 164–172 (2005). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 112.Rolfe DFS & Brown GC Cellular energy utilization and molecular origin of standard metabolic rate in mammals. Physiol. Rev 77, 731–758 (1997). [DOI] [PubMed] [Google Scholar]
  • 113.Chacko BK et al. Methods for defining distinct bioenergetic profiles in platelets, lymphocytes, monocytes, and neutrophils, and the oxidative burst from human blood. Lab. Investig 93, 690–700 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114.van der Windt GJW et al. Mitochondrial Respiratory Capacity Is A Critical Regulator Of CD8+ T Cell Memory Development. Immunity 36, 68 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 115.McMurray J. et al. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. The, (21),. 10.1056/NEJMoa1911303. N. Engl. J. Med 381, 1995–2008 (2019). [DOI] [PubMed] [Google Scholar]
  • 116.Molina JR et al. An inhibitor of oxidative phosphorylation exploits cancer vulnerability. Nat. Med 24, 1036–1046 (2018). [DOI] [PubMed] [Google Scholar]
  • 117.Rath S. et al. MitoCarta3.0: An updated mitochondrial proteome now with sub-organelle localization and pathway annotations. Nucleic Acids Res. 49, D1541–D1547 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 118.Nowinski SM et al. Mitochondrial fatty acid synthesis coordinates oxidative metabolism in mammalian mitochondria. Elife 9, 1–35 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 119.Floyd BJ et al. Mitochondrial Protein Interaction Mapping Identifies Regulators of Respiratory Chain Function. Mol. Cell 63, 621–632 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 120.Brand MD The efficiency and plasticity of mitochondrial energy transduction. Biochem. Soc. Trans 33, 897–904 (2005). [DOI] [PubMed] [Google Scholar]
  • 121.Watt IN, Montgomery MG, Runswick MJ, Leslie AGW & Walker JE Bioenergetic cost of making an adenosine triphosphate molecule in animal mitochondria. Proc. Natl. Acad. Sci. U. S. A 107, 16823–16827 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 122.Hinkle PC P/O ratios of mitochondrial oxidative phosphorylation. Biochim. Biophys. Acta - Bioenerg 1706, 1–11 (2005). [DOI] [PubMed] [Google Scholar]
  • 123.Müller TD et al. P62 Links β-adrenergic input to mitochondrial function and thermogenesis. J. Clin. Invest 123, 469–478 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 124.Kory N. et al. MCART1/SLC25A51 is required for mitochondrial NAD transport. Sci. Adv 6, (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 125.Bricker DK et al. A mitochondrial pyruvate carrier required for pyruvate uptake in yeast, Drosophila, and humans. Science (80-. ). (2012) doi: 10.1126/science.1218099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 126.Herzig S. et al. Identification and functional expression of the mitochondrial pyruvate carrier. Science (80-. ). (2012) doi: 10.1126/science.1218530. [DOI] [PubMed] [Google Scholar]
  • 127.Sharma A. et al. Impaired skeletal muscle mitochondrial pyruvate uptake rewires glucose metabolism to drive whole-body leanness. Elife 8, (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 128.Bertholet AM The Use of the Patch-Clamp Technique to Study the Thermogenic Capacity of Mitochondria. J. Vis. Exp 2021, (2021). [DOI] [PubMed] [Google Scholar]
  • 129.Gerencser AA et al. Quantitative measurement of mitochondrial membrane potential in cultured cells: Calcium-induced de- and hyperpolarization of neuronal mitochondria. J. Physiol (2012) doi: 10.1113/jphysiol.2012.228387. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES